We demonstrate persistent linear dose–response relationships between ALT/AST ratio, BUN or BUN/Cr ratio levels, and depression risk in elderly inpatients, remaining robust after rigorous adjustment for metabolic-inflammatory confounders. The gene discussed is GPT; the disease is depressive disorder.